Revvity Signals Software unveils Signals Clinical solution to accelerate critical clinical trial insights and data-driven decisions

Today, Revvity, Inc. announced that its software and informatics division, Revvity Signals, is unveiling the Signals ClinicalTM solution, a software-as-a-service (SaaS), end-to-end clinical data science platform designed to centralize all clinical trial data, providing fast, actionable insights for quicker clinical decisions and accelerated market delivery of therapeutics. This state-of-the-art solution, when integrated with enterprise-class Spotfire visual analytics, has the potential to redefine how the pharmaceutical, biotechnology, and contract research industries approach clinical trial data, offering an unprecedented level of access and insight to drive forward clinical development and therapeutic innovations.

Kevin Willoe, SVP and general manager of Revvity Signals Software, Inc., emphasized the transformative potential of Signals Clinical, stating, "In the high-stakes realms of pharma, biotech, and contract research, the ability to swiftly and safely bring new treatments to market is paramount. Signals Clinical is our answer to the industry's urgent need for a solution that not only is designed to protect patient safety but also empowers data-driven decision-making with near real-time analytics. By integrating this platform with advanced data visualization tools, we're enabling our customers to navigate the complexities of clinical development with greater ease and efficiency, thereby accelerating the delivery of new drugs to patients."

Centralizing clinical data for accelerated decisions

Signals Clinical centralizes all clinical development data in one location and enables self-service access to clinical trial data, providing users with a complete picture of patient safety, treatment efficacy, and trial progress. This centralization enables rapid, actionable insights, facilitating faster and more informed clinical decisions, and significantly accelerating the time-to-market for essential therapeutics.

Empowering life sciences with advanced analytics

Signals Clinical, when combined with Spotfire not only streamlines the data preparation process but also enhances the delivery of strategic analyses, such as safety, efficacy and cross-study analysis. By reducing the time and resources spent on manual data handling, Signals Clinical allows organizations to focus on delivering critical clinical trial insights and fostering cross-functional collaboration.

Leading with FAIR practices for collaborative data management

Championing FAIR principles, the platform streamlines data preparation, reducing effort and maximizing value. It offers customizable workflows for data management, clinical review, and study monitoring, along with integrated collaboration tools. These features allow queries to be documented and referenced by study managers, enhancing collaboration and boosting overall team efficiency for clinical researchers.

Revvity Signals Software will present its Signals Clinical platform for the first time at the 15th Annual SCOPE conference (Booth #236), February 11-14, in Orlando, Florida.

Source:

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Revvity. (2024, March 26). Revvity Signals Software unveils Signals Clinical solution to accelerate critical clinical trial insights and data-driven decisions. News-Medical. Retrieved on April 23, 2024 from https://www.news-medical.net/news/20240214/Revvity-Signals-Software-unveils-signals-clinical-solution-to-accelerate-critical-clinical-trial-insights-and-data-driven-decisions.aspx.

  • MLA

    Revvity. "Revvity Signals Software unveils Signals Clinical solution to accelerate critical clinical trial insights and data-driven decisions". News-Medical. 23 April 2024. <https://www.news-medical.net/news/20240214/Revvity-Signals-Software-unveils-signals-clinical-solution-to-accelerate-critical-clinical-trial-insights-and-data-driven-decisions.aspx>.

  • Chicago

    Revvity. "Revvity Signals Software unveils Signals Clinical solution to accelerate critical clinical trial insights and data-driven decisions". News-Medical. https://www.news-medical.net/news/20240214/Revvity-Signals-Software-unveils-signals-clinical-solution-to-accelerate-critical-clinical-trial-insights-and-data-driven-decisions.aspx. (accessed April 23, 2024).

  • Harvard

    Revvity. 2024. Revvity Signals Software unveils Signals Clinical solution to accelerate critical clinical trial insights and data-driven decisions. News-Medical, viewed 23 April 2024, https://www.news-medical.net/news/20240214/Revvity-Signals-Software-unveils-signals-clinical-solution-to-accelerate-critical-clinical-trial-insights-and-data-driven-decisions.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Rentschler Biopharma licenses Horizon Discovery’s CHOSOURCE platform to complement cell line development offering for difficult-to-express proteins